TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,045,000 | +241.5% | 13,887 | +21.7% | 0.06% | +243.8% |
| Q1 2022 | $306,000 | -32.9% | 11,410 | +19.3% | 0.02% | -42.9% |
| Q4 2021 | $456,000 | -34.6% | 9,561 | -8.9% | 0.03% | -28.2% |
| Q3 2021 | $697,000 | +2.0% | 10,494 | +19.8% | 0.04% | +5.4% |
| Q2 2021 | $683,000 | -23.4% | 8,757 | -7.2% | 0.04% | -27.5% |
| Q1 2021 | $892,000 | -32.0% | 9,434 | -12.4% | 0.05% | -46.3% |
| Q4 2020 | $1,312,000 | -60.8% | 10,768 | -71.9% | 0.10% | -12.8% |
| Q3 2020 | $3,351,000 | – | 38,354 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |